About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,045 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,045 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7181-7200 of 8,045 trials

CompletedFoundation and Clinical About the Expression of PD-1 in Peripheral Blood T LymphocytesProviding more theoretical basis for the prediction of the efficacy of advanced NSCLC and helping select better advantaged population of NSCLC immunotherapy to maximize the…NCT05792995·Yichang, Hubei Active not recruitingNivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLCThe purpose of this study is to examine the safety and efficacy of combining Nivolumab and low-dose Oxaliplatin with or without Ipilumumab in patients who have had their advanced…NCT04043195·La Jolla, California UnknownIntercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung CancerObjective: To compare the efficacy and safety of chemotherapy plus intercalated EGFR-tyrosine kinase inhibitors (TKI) combination therapy with TKI alone therapy as first-line…NCT02031601·Jinan, Shandong

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingA Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant TumorsPhase I: To evaluate the safety, tolerance and effectiveness of IAP0971 for the treatment of advanced malignant tumors.NCT06581419·Beijing, Beijing Municipality

WithdrawnINCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)The purpose of this study is to assess the efficacy and safety of INCMGA00012 in combination with chemoradiation therapy (CRT) in participants with unresectable, Stage III…NCT04203511

CompletedStudy to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway SignalingThis phase IB trial aims to identify anticancer activity of GSK3052230 in subjects with malignancies with abnormal dependence on FGF pathway signaling.NCT01868022·Duarte, California and 28 others

CompletedA Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of CancerThe main purpose of this observational study with Docetaxel is to determine the number of treatment cycles and the quantity of Doce onkovis needed therefore under the special…NCT01614002·Berlin and 22 others

CompletedSafety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.Radiotherapy is treatment of choice for inoperable lung cancer. Research has shown that the local control rate is low and the radiation often causes pneumonitis and/or esophagitis.NCT00181545·Heerlen, Limburg

CompletedSafety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung CancerThe purpose of this study is to determine whether it is safe to treat lung cancer patients who have undergone an attempt at curative resection with the combination of docetaxel…NCT00883675·Lebanon, New Hampshire and 11 others

CompletedSensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung CancerThis is a prospective diagnostic pilot study to create hypotheses regarding immunocytochemistry (ICC) PD-L1 analysis of pleural effusions in NSCLC patients as compared to the…NCT02855281·Solingen, North Rhine-Westphalia

UnknownInvestigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLCThis project is a real-world exploratory study aiming to explore potential molecular markers detectable at baseline that can enable the prediction of clinical efficacy of…NCT04858828·Guangzhou, Guangdong

UnknownA Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under ChemotherapyWorldwide, non-small cell lung cancer (NSCLC) is one of the most common causes of cancer mortality. Also, the first leading cause of death is lung cancer in Taiwan 2012.NCT03130192·Taichung

WithdrawnTesting the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung CancerThis phase II Lung-MAP treatment trial tests whether carboplatin and pemetrexed with or without selpercatinib works to shrink tumors in patients with RET fusion-positive non-small…NCT05364645·Jonesboro, Arkansas and 264 others

CompletedCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.NCT00019019·Bethesda, Maryland and 1 other

CompletedCombined Application of EBUS and EUS in Lung CancerThis study aims to investigate a diagnostic yield and performance characteristics according to the order of endobronchial ultrasound guided transbronchial needle aspiration…NCT01385111·Goyang-si, Gyeonggi-do

UnknownFirst Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care TherapyPhase I: evaluate the safety and tolerability two different dosing regimens of Thymosin alpha 1 in patients with advanced EGFR mutation positive NSCLC on Standard of Care (SoC)…NCT02906163·Frosinone and 4 others

CompletedEarly Palliative Care in Advanced Lung and Gastrointestinal MalignanciesThe purpose of this study is to compare two types of care - standard oncology care and standard oncology care with early palliative care (started soon after diagnosis) to see…NCT01401907·Boston, Massachusetts

CompletedPhase 1/1b Study of MGCD516 in Patients With Advanced CancerMGCD516 is a receptor tyrosine kinase (RTK) inhibitor shown in preclinical models to inhibit a closely related spectrum of RTKs including MET, AXL, MER, and members of the VEGFR…NCT02219711·Birmingham, Alabama and 42 others

No longer availableExpanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)This is an expanded access protocol designed to make Lucanix® available to subjects with advanced non-small cell lung cancer (NSCLC) who are not eligible for the Phase III…NCT01279798·San Diego, California

CompletedPalliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung CancerThe study is designed as a non-randomized Phase 2 clinical intervention study.NCT05440916·Golnik and 2 others

PreviousPage 360 of 403Next